http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112684186-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 |
| filingDate | 2020-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112684186-B |
| titleOfInvention | Biomarker and kit for predicting MCI (diabetes mellitus) occurrence risk of type 2 diabetes mellitus patient and application of biomarker and kit |
| abstract | The invention relates to the field of medicines, and discloses a group of biomarkers and a kit for predicting MCI risk of type 2 diabetes patients and application thereof. The biomarkers include optic neuroproteins, glycogen synthase kinase-3 beta and Ser 9-phosphorylated glycogen synthase kinase-3 beta. The increase of the biomarker can be used for evaluating MCI, has the characteristics of high accuracy, high detection speed, low cost, small wound and easy acceptance by patients, and provides a scientific and effective early prediction scheme for MCI generation of type 2 diabetes patients. The kit can screen MCI in a large range of people, and can complete detection only by collecting peripheral blood, so that large-range screening of the elderly population becomes possible. |
| priorityDate | 2020-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.